Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Molnar-Kimber

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Experimental Medicine|February 1, 1980
Absence of H-2 restriction in primary and secondary mixed-lymphocyte reactions to strong M1s determinantsK Molnar-Kimber, J Sprent
Springer Seminars in Immunopathology|August 1, 1980
T cell recognition of antigen in vivo: role of the H-2 complexJ Sprent, R Korngold, K Molnar-Kimber
Agents and Actions|January 1, 1993
Modulation of TNF alpha and IL-1 beta from endotoxin-stimulated monocytes by selective PDE isozyme inhibitorsK Molnar-Kimber, L Yonno, R Heaslip, et al.
Medicinal Research Reviews|January 1, 1994
Rapamycin: a novel immunosuppressive macrolideS N Sehgal, K Molnar-Kimber, T D Ocain, et al.
The Journal of Experimental Medicine|December 1, 1981
T cell clones with dual specificity for M1s and various major histocompatibility complex determinantsS R Webb, K Molnar-Kimber, J Bruce, et al.
Vaccine|July 1, 1991
Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogsM Chengalvala, M D Lubeck, A R Davis, et al.
Virology|August 1, 1990
Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intronB B Mason, A R Davis, B M Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cellsR Abdul-Ghani, P Ohana, I Matouk, et al.
Human Gene Therapy|June 2, 1998
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Experimental Medicine|February 1, 1980
Absence of H-2 restriction in primary and secondary mixed-lymphocyte reactions to strong M1s determinantsK Molnar-Kimber, J Sprent
Springer Seminars in Immunopathology|August 1, 1980
T cell recognition of antigen in vivo: role of the H-2 complexJ Sprent, R Korngold, K Molnar-Kimber
Agents and Actions|January 1, 1993
Modulation of TNF alpha and IL-1 beta from endotoxin-stimulated monocytes by selective PDE isozyme inhibitorsK Molnar-Kimber, L Yonno, R Heaslip, et al.
Medicinal Research Reviews|January 1, 1994
Rapamycin: a novel immunosuppressive macrolideS N Sehgal, K Molnar-Kimber, T D Ocain, et al.
The Journal of Experimental Medicine|December 1, 1981
T cell clones with dual specificity for M1s and various major histocompatibility complex determinantsS R Webb, K Molnar-Kimber, J Bruce, et al.
Vaccine|July 1, 1991
Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogsM Chengalvala, M D Lubeck, A R Davis, et al.
Virology|August 1, 1990
Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intronB B Mason, A R Davis, B M Bhat, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000
Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cellsR Abdul-Ghani, P Ohana, I Matouk, et al.
Human Gene Therapy|June 2, 1998
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.
Pageof 2